BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32817366)

  • 1. Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice.
    Alsamman S; Christenson SA; Yu A; Ayad NME; Mooring MS; Segal JM; Hu JK; Schaub JR; Ho SS; Rao V; Marlow MM; Turner SM; Sedki M; Pantano L; Ghoshal S; Ferreira DDS; Ma HY; Duwaerts CC; Espanol-Suner R; Wei L; Newcomb B; Mileva I; Canals D; Hannun YA; Chung RT; Mattis AN; Fuchs BC; Tager AM; Yimlamai D; Weaver VM; Mullen AC; Sheppard D; Chen JY
    Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32817366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells.
    Chen JY; Newcomb B; Zhou C; Pondick JV; Ghoshal S; York SR; Motola DL; Coant N; Yi JK; Mao C; Tanabe KK; Bronova I; Berdyshev EV; Fuchs BC; Hannun Y; Chung RT; Mullen AC
    Sci Rep; 2017 Mar; 7():44867. PubMed ID: 28322247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPK stimulation inhibits YAP/TAZ signaling to ameliorate hepatic fibrosis.
    Shihan MH; Sharma S; Cable C; Prathigudupu V; Chen A; Mattis AN; Chen JY
    Sci Rep; 2024 Mar; 14(1):5205. PubMed ID: 38433278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury.
    Konishi T; Schuster RM; Lentsch AB
    Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G471-G482. PubMed ID: 29351389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting acid ceramidase ameliorates fibrosis in mouse models of non-alcoholic steatohepatitis.
    Yu A; Cable C; Sharma S; Shihan MH; Mattis AN; Mileva I; Hannun YA; Duwaerts CC; Chen JY
    Front Med (Lausanne); 2022; 9():881848. PubMed ID: 36275798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
    Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
    Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis.
    Toyama T; Looney AP; Baker BM; Stawski L; Haines P; Simms R; Szymaniak AD; Varelas X; Trojanowska M
    J Invest Dermatol; 2018 Jan; 138(1):78-88. PubMed ID: 28870693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
    Yu HX; Yao Y; Bu FT; Chen Y; Wu YT; Yang Y; Chen X; Zhu Y; Wang Q; Pan XY; Meng XM; Huang C; Li J
    Mol Immunol; 2019 Mar; 107():29-40. PubMed ID: 30639476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation.
    Zhang K; Chang Y; Shi Z; Han X; Han Y; Yao Q; Hu Z; Cui H; Zheng L; Han T; Hong W
    Sci Rep; 2016 Jul; 6():30029. PubMed ID: 27435808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver fibrosis.
    Du K; Maeso-Díaz R; Oh SH; Wang E; Chen T; Pan C; Xiang K; Dutta RK; Wang XF; Chi JT; Diehl AM
    Hepatology; 2023 Jun; 77(6):1998-2015. PubMed ID: 36815382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
    Perumal N; Perumal M; Halagowder D; Sivasithamparam N
    Biochimie; 2017 Sep; 140():10-19. PubMed ID: 28552397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation.
    Shanzer M; Adler J; Ricardo-Lax I; Reuven N; Shaul Y
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1678-1683. PubMed ID: 28154141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased acid ceramidase expression depends on upregulation of androgen-dependent deubiquitinases, USP2, in a human prostate cancer cell line, LNCaP.
    Mizutani N; Inoue M; Omori Y; Ito H; Tamiya-Koizumi K; Takagi A; Kojima T; Nakamura M; Iwaki S; Nakatochi M; Suzuki M; Nozawa Y; Murate T
    J Biochem; 2015 Oct; 158(4):309-19. PubMed ID: 25888580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquiritigenin inhibits hepatic fibrogenesis and TGF-β1/Smad with Hippo/YAP signal.
    Lee EH; Park KI; Kim KY; Lee JH; Jang EJ; Ku SK; Kim SC; Suk HY; Park JY; Baek SY; Kim YW
    Phytomedicine; 2019 Sep; 62():152780. PubMed ID: 31121384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose dependent actions of LCL521 on acid ceramidase and key sphingolipid metabolites.
    Bai A; Bielawska A; Rahmaniyan M; Kraveka JM; Bielawski J; Hannun YA
    Bioorg Med Chem; 2018 Dec; 26(23-24):6067-6075. PubMed ID: 30448190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation.
    Li L; Zhou J; Li Q; Xu J; Qi J; Bian H
    Biomed Pharmacother; 2018 Oct; 106():83-91. PubMed ID: 29957470
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Yan J; Hu B; Shi W; Wang X; Shen J; Chen Y; Huang H; Jin L
    Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G720-G728. PubMed ID: 33728992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The signaling protein Wnt5a promotes TGFβ1-mediated macrophage polarization and kidney fibrosis by inducing the transcriptional regulators Yap/Taz.
    Feng Y; Liang Y; Zhu X; Wang M; Gui Y; Lu Q; Gu M; Xue X; Sun X; He W; Yang J; Johnson RL; Dai C
    J Biol Chem; 2018 Dec; 293(50):19290-19302. PubMed ID: 30333225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis.
    Liu F; Lagares D; Choi KM; Stopfer L; Marinković A; Vrbanac V; Probst CK; Hiemer SE; Sisson TH; Horowitz JC; Rosas IO; Fredenburgh LE; Feghali-Bostwick C; Varelas X; Tager AM; Tschumperlin DJ
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L344-57. PubMed ID: 25502501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.